CRISPR Therapeutics AG (CRSP)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Samarth Kulkarni |
| Employees: | 460 |
| Web site: | crisprtx.com |
|
BAARERSTRASSE 14, ZUG, V8, CH-6300
6173154600
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases. The company's lead product candidate is CTX001, an ex-viggered therapy for treating patients suffering from transfusion-dependent beta-thalassemia or severe sickle cell disease. It also develops CTX110, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting cluster of differentiation 19 positive malignancies.
Please log in first to see chart